NephMadness
@nephmadness
#NephMadness 2024 on the #AJKDBlog: bit.ly/3IltrrQ | @AJKDonline
ID: 1463195322
http://www.nephmadness.com 27-05-2013 21:49:03
3,3K Tweet
9,9K Takipçi
1,1K Takip Edilen
Matthew Sparks, MD Husam Alzayer Pascale Khairallah AJKD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Someone said it before me, but I cannot find the original post. Prognostic equations - CKD progression: old trusty KRFE versus this one? x.com/hswapnil/statu…
Matthew Sparks, MD Husam Alzayer Pascale Khairallah AJKD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Also, eGFR equations: CKD-EPI without race versus this one (interesting discussions from Ottowa Nephrology ground rounds+ the expert Pierre Delanaye ) Although, you might say KDIGO rather pushes for cystatin C, globally we are not there just yet youtu.be/2gScckBmFDw?si…
Matthew Sparks, MD Pascale Khairallah AJKD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Or does nephrin fit into the argument for novel classification of GN (academic.oup.com/ndt/article/38…) versus traditional histological classification?
AJKD Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Maybe something about complement inhibition in diverse GNs: Iptacopan in IgA vs C3GN (presented last weekend during #ERA24; hopefully it will be published soon) x.com/Nephro_Sparks/… x.com/ERAkidney/stat…
AJKD Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Maybe instead of animal house you could do plants, and call it green house. Could highlight different plants.. maybe asparagus, licorice, beets, etc. I’m sure there are even better examples of different plants and their effects or side effects on the kidney.
AJKD Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Balkan nephropathy vs mesoamerican nephropathy.
Cristina Popa AJKD Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Emilie Cornec-Le Gall Roser Torra Personally, I would have been very interested in a topic about ethics in genetic, such as the question of preimplantation diagnosis or incidental finding in exomes/genomes (not to write it but to read it ☺️)
Suggestions for next year NephMadness: biomarkers in transplant region, with the 4 teams being donor-derived cell free DNA, blood gene expression panels, urine gene expression panels and torquetenovirus.
We are still accepting ideas for #NephMadness 2025 - keep them coming! buff.ly/3UUGAy8 Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott
Swapnil Hiremath @[email protected] Eric Weinhandl Braden Manns Marcello Tonelli Withings (even before access to drugs is a factor). Knowing the value/cost effectiveness of screening in this new era as you say is key. Maybe screening should be a topic for #nephmadness next year if it hasn’t been suggested already? 2/2
Sinead Stoneman Eric Weinhandl Braden Manns Marcello Tonelli Withings Screening versus not screening would be good topic for NephMadness #NephMadness This (via Jeremy Sussman ) ncbi.nlm.nih.gov/pmc/articles/P… is a (flawed if you ask me) argument against screening - but would also be a good forum to discuss cost of newer drugs as Bernie Sanders has said!
We are still accepting ideas for #NephMadness 2025 - keep them coming! buff.ly/3UUGAy8 Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott
Congrats to A. Ersin Yassa and Yasemin Balin, the first NephMadness tournament winners at #NKFClinicals! They spoke with our own Joel Topf (Joel M. Topf, MD FACP) onsite about the experience. #nephrology #kidney #NephMadness buff.ly/455NZiJ
Congratulations to the renal department of Mater University Hospital, winners of Irish NephMadness 2nd year in a row!! #ins24 Irish Nephrology Society Mater Hospital Trauma credit to Sinead Stoneman for graphic wizardry
NephMadness Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Have you done low protein diets versus normal prtoein diets?
Joel M. Topf, MD FACP NephMadness Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Biopsy or no biopsy if you can make a diagnosis from blood tests: Biopsy v no biopsy for PLA2R membranous, Biopsy v no biopsy for ANCA+ GN, Biopsy v no biopsy for multiple myeloma with renal involvement. Biopsy or no biopsy if genetic testing shows a Col4 mutation.
